Search results
Psoriatic Arthritis Drugs Comparably Improve Joint Outcomes
Medscape· 3 days agoReal-world study data suggest there is little difference among five drug classes commonly used to...
J&J (JNJ) Seeks Expanded Use of Tremfya for Crohn's Disease
Zacks via Yahoo Finance· 6 hours agoJ&J (JNJ) seeks label expansion for Tremfya for treating moderately to severely active Crohn's...
Izokibep Marches on for Psoriatic Arthritis
MedPage Today· 6 days agoAfter 16 weeks of treatment in the randomized, placebo-controlled study, 40% and 43% of patients receiving 160 mg of izokibep weekly or biweekly,...
Psoriasis study shows high level of arthritis symptoms in patients
Medical Xpress· 3 days agoThe 25% figure confirms existing knowledge that up to a third will go on to develop psoriatic ...
Izokibep Enthesitis Benefit Lacking in Phase 2b/3 PsA Trial
Medscape· 3 days agoThe primary efficacy endpoint was met, but the novel small molecule therapeutic did not reduce...
Study led by UChicago Medicine physician finds new | Newswise
Newswise· 5 days agoA medication used for psoriasis and psoriatic arthritis is proving to be an effective treatment for moderate to severe ulcerative colitis in the findings ...
Phase 3 Trial Supports Ixekizumab in Juvenile PsA, ERA
Medscape· 2 days agoIxekizumab (Taltz), an interleukin-17A inhibitor that's already approved for the treatment of ...
Skill Checkup: A Man With Treated PsA and Abdominal Pain
Medscape· 4 days agoA 48-year-old Asian man in the United States presents with fatigue, weakness, and a dull pain in his...
FDA Approves Skyrizi for Ulcerative Colitis
Medscape· 3 days agoThe approval is the fourth indication for the anti–interleukin 23 monoclonal antibody after approval for Crohn's disease, psoriatic arthritis, and plaque...
Vanguard Group Inc. Acquires 6,572 Shares of Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 4 days agoVanguard Group Inc. boosted its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 0.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission ...